Laxacin
- Product NDC
- 50488-0901
- 11-digit product format
- 504880901
- Labeler code
- 50488
- Product ID
- 50488-0901_1b45f6d1-4436-4b3a-813b-7043c0d0fad6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate sodium and sennosides
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alexso, Inc
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-10-15
- Substance
- DOCUSATE SODIUM; SENNOSIDES A AND B
- Active strength
- 50; 8.6 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Laxacin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SENNOSIDES A AND B | 8.6 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
| 1B5FPI42EN | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50488-0901-1 | Laxacin | 100 in 1 BOTTLE | TABLET | 100 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50488-0901-1 | EA - Each | 50488-0901 | 933d71c3-b01d-44ff-b256-0bee20827ae8 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50488-0901 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO, INC] | 8 | Current NDC, Legacy NDC, 1 package rows | 20241208_0df9abaf-3997-4dde-8003-ae3d8d07cf39.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Publix Fiber Therapy Sugar Free | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | ed3dc80a-a243-4013-9886-b148e3e3b662 | 2025-10-28 | Warnings | M007 |
| Childrens Oral Saline Laxative | MAGNESIUM HYDROXIDE | WAL-MART STORES,INC., | a2eb50ab-851a-4abb-a12f-6d9d8b0cb6bc | 2025-10-27 | Warnings | M007 |
| equate Fiber Therapy | METHYLCELLULOSE | Wal-Mart Stores,Inc., | 7acc30b4-e946-42cd-8eec-cf15159d478d | 2025-10-27 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | CVS Pharmacy | c56e010a-7503-3e1c-e053-2a95a90a2b85 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Major Pharmaceuticals | c194c40c-c732-2f03-e053-2a95a90a7a40 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Pharmacy Value Alliance LLC | 8a6d6729-f6eb-4f68-e053-2a95a90a5c9e | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Cardinal Health | c2b33e78-6ab7-1785-e053-2995a90a9c4f | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | PSN | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SBD | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SY | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | SY | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | PSN | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | PSN | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 2106884 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SBD | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SBD | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 2106884 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SY | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SY | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | SY | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | SY | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50488-0901-1 | 50488090101 | 100 TABLET in 1 BOTTLE (50488-0901-1) | 100 tablet | 2018-10-15 | 0000-00-00 | No | No | Current |